A Multidisciplinary "Integrated Management Team to Improve Maternal-Child Outcomes (IMPROVE)" Intervention to Improve Maternal and Child Outcomes in Lesotho
IMPROVE
1 other identifier
interventional
1,004
0 countries
N/A
Brief Summary
This study aims to improve maternal and child health (MCH) outcomes by implementing and evaluating a multidisciplinary "Integrated Management Team to Improve Maternal-Child Outcomes (IMPROVE)" intervention to increase MCH, antiretroviral therapy (ART), and HIV services uptake and retention in Lesotho. The proposed intervention will focus efforts to improve the effectiveness of existing village health workers (VHW) and HIV support organizations (Lesotho Network of AIDS Service Organizations \[LENASO\] and Mothers2Mothers \[M2M\]) based at the facility and coordination between the facility and community. The IMPROVE intervention includes: (1) Multidisciplinary integrated management teams to coordinate patient-focused and outcome-oriented PMTCT and MCH services; (2) Enhanced Positive Health, Dignity, and Prevention (PHDP)-focused counseling and skills-building training and job aids; and (3) Increased early community-based counseling and support for first (antenatal care clinic) ANC attendees with particular attention to HIV-positive women to minimize loss to follow-up. The study will be a cluster randomized design with facilities randomized to receive the IMPROVE intervention or routine services offering the national standard of care. A cohort of HIV-positive and HIV-negative pregnant women will be enrolled and prospectively followed every three months through pregnancy and until the participant's child reaches 24 months of age. The primary HIV objectives will be to evaluate the effect of the intervention on retention in HIV care, viral suppression, adherence to ART in HIV-positive women, and HIV retesting in HIV-negative women. The investigators will also assess the effect of the IMPROVE intervention on general MCH indices including antenatal care (ANC) attendance, facility delivery, family planning, and immunization coverage. Secondary objectives include evaluation of adherence self-efficacy (HIV positive) or prevention self-efficacy (HIV negative), depression and stigma as well as disclosure, knowledge of partner status, and identification of discordant couples in intervention versus control facilities. Analysis of the cost-effectiveness of the IMPROVE intervention will also be conducted. In addition, qualitative interviews and focus group discussions will be conducted with study women, health care workers (HCW), LENASO, and VHWs to evaluate the feasibility and acceptability of integrating this intervention into routine care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2016
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 27, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2020
CompletedFirst Submitted
Initial submission to the registry
October 5, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedOctober 22, 2020
October 1, 2020
3 years
October 5, 2020
October 19, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Retention
Proportion of participants retained in care
at 24 months post partum
ART Adherence
Proportion of HIV-positive women on treatment with \>95% adherence based on effective pill count
at 24 months postpartum
Viral suppression rate
Proportion of HIV-positive women with undetectable viral load
at 24 months postpartum
HIV retesting rate
Proportion of HIV-negative women who received additional HIV testing
at 24 months postpartum
Targeted MCH health seeking behaviors
Proportion of women who delivered at a health facility
At 24 months postpartum
Secondary Outcomes (4)
General MCH Outcomes
24 months postpartum
HIV outcomes
at 6 weeks of infant age
Depression
at enrollment
Cost-effectiveness of implementing the IMPROVE intervention
At 24 months postpartum
Study Arms (2)
IMPROVE
EXPERIMENTALA cluster of 6 health facilities are to receive the IMPROVE Intervention. The IMPROVE intervention includes: (1) Multidisciplinary integrated management teams to coordinate patient-focused and outcome-oriented PMTCT and MCH services; (2) Enhanced Positive Health, Dignity, and Prevention (PHDP)-focused counseling and skills-building training and job aids; and (3) Increased early community-based counseling and support for first (antenatal care clinic) ANC attendees with particular attention to HIV-positive women to minimize loss to follow-up.
Standard of care
NO INTERVENTIONA cluster of 6 health facilities receive Standard of Care. Routine health facility services offering the national standard of care for pregnant and breastfeeding women in Lesotho
Interventions
Health system interventions that include: (1) Multidisciplinary integrated management teams to coordinate patient-focused and outcome-oriented PMTCT and MCH services; (2) Enhanced Positive Health, Dignity, and Prevention (PHDP)-focused counseling and skills-building training and job aids; and (3) Increased early community-based counseling and support for first (antenatal care clinic) ANC attendees
Eligibility Criteria
You may qualify if:
- Pregnant woman attending first ANC visit at a study facility . There is no age restriction for study enrollment as young pregnant women in Lesotho are consider emancipated.
- HIV status known at time of enrollment
- Residing in an area around a study facility
- Willing and able to provide informed consent
You may not qualify if:
- Pregnant women attending 2nd or later ANC visits
- Attending care at study facility temporarily
- Significant medical or psychological condition that would preclude active study participation
- Inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Elizabeth Glaser Pediatric AIDS Foundationlead
- Ministry of Health, Lesothocollaborator
- United States Agency for International Development (USAID)collaborator
- Avenir Healthcollaborator
- Population Councilcollaborator
- Johns Hopkins Universitycollaborator
Related Publications (1)
Beres LK, Chabela M, Masitha M, Catanzarite Z, Tukei VJ, Mofenson L, Tiam A, Greenberg L, Mokone M, Thabelo R, Nchephe M, Mots'oane T, Guay L, Knowlton AR. An integrated, multidisciplinary management team intervention to improve patient-centeredness, HIV, and maternal-child outcomes in Lesotho: formative research on participatory implementation strategies. BMC Health Serv Res. 2024 Dec 18;24(1):1590. doi: 10.1186/s12913-024-12049-x.
PMID: 39696296DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Appolinaire Tiam, MD
Elizabeth Glaser Pediatric AIDS Foundation
- PRINCIPAL INVESTIGATOR
Laura A Guay, MD
Elizabeth Glaser Pediatric AIDS Foundation
- PRINCIPAL INVESTIGATOR
Lynne Mofenson, MD
Elizabeth Glaser Pediatric AIDS Foundation
- PRINCIPAL INVESTIGATOR
Vincent Tukei, MD
Elizabeth Glaser Pediatric AIDS Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 5, 2020
First Posted
October 22, 2020
Study Start
July 27, 2016
Primary Completion
July 31, 2019
Study Completion
September 30, 2020
Last Updated
October 22, 2020
Record last verified: 2020-10
Data Sharing
- IPD Sharing
- Will not share
The dataset generated and used for this analysis is available from the study biostatistician (hhoffman@gwu.edu) on reasonable request